Jane Doe

So, he's not coming back as CEO, I should make that clear. But he is coming back to the Drugmakers Board of Directors.

So, he's not coming back as CEO, I should make that clear. But he is coming back to the Drugmakers Board of Directors.

So, he's not coming back as CEO, I should make that clear. But he is coming back to the Drugmakers Board of Directors.

Yeah, they really highlight the what have you done for me lately mindset of investors. So even though objectively on paper, Novo Nordisk has been phenomenally successful, investors are so focused on the future. So that's one thing. But I would also say it just illustrates how big people think this broad market could become. Really, it's on a trajectory to just be one of the biggest of all time.

Yeah, they really highlight the what have you done for me lately mindset of investors. So even though objectively on paper, Novo Nordisk has been phenomenally successful, investors are so focused on the future. So that's one thing. But I would also say it just illustrates how big people think this broad market could become. Really, it's on a trajectory to just be one of the biggest of all time.

Yeah, they really highlight the what have you done for me lately mindset of investors. So even though objectively on paper, Novo Nordisk has been phenomenally successful, investors are so focused on the future. So that's one thing. But I would also say it just illustrates how big people think this broad market could become. Really, it's on a trajectory to just be one of the biggest of all time.

These GLP-1 type drugs... work not only for diabetes and weight loss, but it seems like with each passing week, there's some piece of information, a study or whatever, that seems to suggest some new benefit.

These GLP-1 type drugs... work not only for diabetes and weight loss, but it seems like with each passing week, there's some piece of information, a study or whatever, that seems to suggest some new benefit.

These GLP-1 type drugs... work not only for diabetes and weight loss, but it seems like with each passing week, there's some piece of information, a study or whatever, that seems to suggest some new benefit.

And so I think any sort of setback is kind of viewed as a threat and could lead to something like what we're seeing.

And so I think any sort of setback is kind of viewed as a threat and could lead to something like what we're seeing.

And so I think any sort of setback is kind of viewed as a threat and could lead to something like what we're seeing.

You know the fucking headlines? Aaron Rodgers and Joe Rogan by the island.

You know the fucking headlines? Aaron Rodgers and Joe Rogan by the island.

You know the fucking headlines? Aaron Rodgers and Joe Rogan by the island.

Yeah, it's a capisce.

Yeah, it's a capisce.

Yeah, it's a capisce.

I don't know what he said. I was laughing at it going, what the fuck is this? I don't think he does either.

I don't know what he said. I was laughing at it going, what the fuck is this? I don't think he does either.